评价美国急性缺血性脑卒中患者二级预防中基于证据的双联抗血小板治疗。
Evaluation of Evidence-Based Dual Antiplatelet Therapy for Secondary Prevention in US Patients With Acute Ischemic Stroke.
机构信息
Department of Neurology, University of Texas Southwestern Medical Center, Dallas.
Duke Clinical Research Institute, Duke University, Durham, North Carolina.
出版信息
JAMA Intern Med. 2022 May 1;182(5):559-564. doi: 10.1001/jamainternmed.2022.0323.
Abstract
This cohort study examines patterns in prescriptions of dual antiplatelet therapy after publication of important trials and release of updated guidelines.
摘要
本队列研究考察了重要试验发表后和更新指南发布后双重抗血小板治疗处方模式。
相似文献
1
Evaluation of Evidence-Based Dual Antiplatelet Therapy for Secondary Prevention in US Patients With Acute Ischemic Stroke.评价美国急性缺血性脑卒中患者二级预防中基于证据的双联抗血小板治疗。
JAMA Intern Med. 2022 May 1;182(5):559-564. doi: 10.1001/jamainternmed.2022.0323.
2
Antiplatelet Therapy for Transient Ischemic Attack and Minor Stroke.短暂性脑缺血发作和轻度卒中的抗血小板治疗
Stroke. 2020 Nov;51(11):3472-3474. doi: 10.1161/STROKEAHA.120.031763. Epub 2020 Sep 25.
3
Dual Antiplatelet Therapy for Minor Stroke and High-Risk Transient Ischemic Attack.小卒中与高危短暂性脑缺血发作的双联抗血小板治疗
Stroke. 2018 Sep;49(9):2278-2279. doi: 10.1161/STROKEAHA.118.022696.
4
Dual antiplatelet therapy with clopidogrel and aspirin for secondary stroke prevention.氯吡格雷和阿司匹林双重抗血小板治疗用于二级卒中预防。
Curr Cardiol Rep. 2015 Oct;17(10):89. doi: 10.1007/s11886-015-0642-4.
5
[Among patients with mild ischemic stroke or high-risk TIA, does combined clopidogrel-aspirin therapy initiated within 72hours after stroke onset and given for 21 days reduce the recurrence of stroke at 90 days compared to aspirin alone, and is it safe?].[在轻度缺血性中风或高危短暂性脑缺血发作患者中，与单独使用阿司匹林相比，在中风发作后72小时内开始联合使用氯吡格雷和阿司匹林治疗21天，是否能降低90天时中风的复发率，以及这种治疗是否安全？]
Rev Med Interne. 2024 Apr;45(4):251-252. doi: 10.1016/j.revmed.2024.02.002. Epub 2024 Feb 22.
6
7
Balancing Benefits and Risks of Long-Term Antiplatelet Therapy in Noncardioembolic Transient Ischemic Attack or Stroke.平衡非心源性短暂性脑缺血发作或卒中患者长期抗血小板治疗的获益与风险。
Stroke. 2021 Oct;52(10):3258-3265. doi: 10.1161/STROKEAHA.120.031755. Epub 2021 Jul 26.
8
Dual antiplatelet therapy with clopidogrel and aspirin after ischemic stroke: A review of the evidence.缺血性卒中后氯吡格雷与阿司匹林联合抗血小板治疗：证据综述
Am J Health Syst Pharm. 2015 Oct 1;72(19):1623-9. doi: 10.2146/ajhp140804.
9
Antiplatelet therapy for transient ischaemic attack and minor ischaemic stroke.短暂性脑缺血发作和小卒中的抗血小板治疗。
Br J Hosp Med (Lond). 2020 Jun 2;81(6):1-3. doi: 10.12968/hmed.2020.0121. Epub 2020 Jun 12.
10
Efficacy and safety of clopidogrel and/or aspirin for ischemic stroke/transient ischemic attack: An overview of systematic reviews and meta-analysis.氯吡格雷和/或阿司匹林治疗缺血性卒中和/或短暂性脑缺血发作的疗效和安全性：系统评价和荟萃分析概述。
Medicine (Baltimore). 2021 Dec 17;100(50):e27804. doi: 10.1097/MD.0000000000027804.
引用本文的文献
1
Uptake of Dual Antiplatelet Therapy After High-Risk Transient Ischemic Attack at a University Hospital.大学医院高危短暂性脑缺血发作后双联抗血小板治疗的应用情况
Neurohospitalist. 2024 Oct 9:19418744241289625. doi: 10.1177/19418744241289625.
2
Cost-Effectiveness of Increased Use of Dual Antiplatelet Therapy After High-Risk Transient Ischemic Attack or Minor Stroke.高危短暂性脑缺血发作或小卒中后增加双联抗血小板治疗的成本效益。
J Am Heart Assoc. 2024 Apr 2;13(7):e032808. doi: 10.1161/JAHA.123.032808. Epub 2024 Mar 27.
3
Appropriate use of antiplatelet medications following transient ischemic attacks and stroke: a 9-year study from the Middle East.短暂性脑缺血发作和中风后抗血小板药物的合理使用：来自中东的9年研究
Front Neurol. 2023 Nov 9;14:1269292. doi: 10.3389/fneur.2023.1269292. eCollection 2023.
4
Determinants and Temporal Trends of Dual Antiplatelet Therapy After Mild Noncardioembolic Stroke.轻度非心源性卒后双联抗血小板治疗的决定因素及时间趋势。
Stroke. 2023 Oct;54(10):2552-2561. doi: 10.1161/STROKEAHA.123.043769. Epub 2023 Sep 7.
5
Analysis of Prescriptions for Dual Antiplatelet Therapy After Acute Ischemic Stroke.急性缺血性脑卒中后双联抗血小板治疗处方分析。
JAMA Netw Open. 2022 Jul 1;5(7):e2224157. doi: 10.1001/jamanetworkopen.2022.24157.
Zotero 插件